Acute Bilateral Pulmonary Opacities Associated With Use of Tocilizumab

J Clin Rheumatol. 2015 Oct;21(7):382-5. doi: 10.1097/RHU.0000000000000304.

Authors

James P Utz¹, Praveen K Jinnur, Eunhee S Yi, Jay H Ryu, David E Midthun, John M Davis 3rd

Affiliation

¹ Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester, MN Utz.James@mayo.edu Department of Pathology and Laboratory Medicine Mayo Clinic Rochester, MN Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester, MN Department of Rheumatology Mayo Clinic Rochester, MN.

PMID: 26398471
DOI: 10.1097/RHU.0000000000000304

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Lung Injury / chemically induced*
Acute Lung Injury / diagnosis
Acute Lung Injury / therapy
Antibodies, Monoclonal, Humanized / adverse effects*
Cogan Syndrome / drug therapy*
Humans
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
tocilizumab